Fisher & Paykel Healthcare raises earnings guidance to NZ$320m-NZ$370m due to high hospital demand.

Fisher & Paykel Healthcare, a NZ-based respiratory devices firm, raises earnings guidance due to high demand from hospitals. The company now anticipates its net profit to be between NZ$320m and NZ$370m for the financial year ending Mar 2025, up from NZ$310m to NZ$360m earlier. Revenue remains unchanged at NZ$1.9bn-NZ$2bn. The growth is attributed to strong demand, improved clinical care, and new OSA masks in the homecare business.

August 22, 2024
7 Articles